PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Hospitals with neurology residency programs more likely to administer life-saving clot-busting drugs

tPA found underused; getting it depends on where patients are treated

2013-11-07
(Press-News.org) Contact information: Stephanie Desmon
sdesmon1@jhmi.edu
410-955-8665
Johns Hopkins Medicine
Hospitals with neurology residency programs more likely to administer life-saving clot-busting drugs tPA found underused; getting it depends on where patients are treated Stroke patients treated at hospitals with neurology residency programs are significantly more likely to get life-saving clot-busting drugs than those seen at other teaching or non-teaching hospitals, new Johns Hopkins-led research suggests.

The findings, described online last week in the journal Neurology, suggest that patients at academic medical centers with neurology residency programs likely benefit from having stroke specialists on hand 24 hours a day, seven days a week. These physicians have more experience with the use of tissue plasminogen activator (tPA) and are likely more confident in using the stroke treatment, which can be deadly if used in the wrong situations, the researchers say.

"The use of tPA within three hours of stroke symptom onset increases the chances of a better outcome by 30 percent and has revolutionized stroke treatment," says study leader Yogesh Moradiya, M.D., a neuro-critical care fellow in the Department of Neurology at the Johns Hopkins University School of Medicine. "But the data show there is a massive underutilization of this drug, which is considered the gold standard of treatment for patients with the most common type of stroke. And our research finds that where you are treated seems to determine whether or not you receive it."

Moradiya conducted the research with colleagues at SUNY Downstate Medical Center in Brooklyn, N.Y., when he was a neurology resident there.

The drug tPA is used only for patients with ischemic stroke, the most common type of stroke, which occurs as a result of an obstruction in a blood vessel supplying blood to the brain. It should not be used in cases of hemorrhagic stroke, marked by bleeding in the brain as the result of a broken blood vessel. Roughly 700,000 Americans each year suffer strokes, which may cause death or serious disability in the form of weakness, loss of sensation, and difficulty with speaking, seeing, or walking.

Nationwide, Moradiya says, approximately 5 percent of ischemic stroke patients receive tPA, which is injected into a vein only after a CT scan is quickly done to rule out hemorrhagic stroke. Researchers believe that approximately 15 percent of ischemic stroke patients could benefit from tPA. The decision to give the clot-busting drug comes after physicians also consider a variety of factors that could increase the risk of deadly bleeding, including size of the stroke, the patient's other illnesses and age.

In the new study, Moradiya and his colleagues analyzed 11 years of data from the U.S. Department of Health and Human Services' National Inpatient Sample, looking at more than 700,000 cases of ischemic stroke. Over the study period, they found that more than 71,000 stroke patients were treated at hospitals with neurology residency programs (10 percent), 207,208 were treated at other teaching hospitals (29 percent), and the rest were treated at non-teaching (community) hospitals. The rate of tPAuse ranged from .96 percent of stroke patients at the 140 hospitals with neurology residency programs in 2000 to 6.25 percent in 2010, from .82 percent in other teaching hospitals to 4.86 percent over the time period, and from .82 percent to 3.83 percent at non-teaching hospitals.

When tPA was first widely adopted, Moradiya says, physicians felt that very old patients, those 80 and older, should not be treated with tPA. Later research, however, found that these elderly patients did just as well as younger ones, so many hospitals have routinely given them the clot-buster since. The new study found that this population routinely gets tPA at the same rate as younger patients at neurology residency program hospitals, but at much lower rates at other hospitals.

"As patients get older, the rates of tPA utilization at hospitals without neurology residency programs go down in a straight line with advancing age," Moradiya says.

He says the reluctance to give tPA at those hospitals could be related to the dangers associated with the drugs. In 6 percent of cases, he says, the drug can cause severe bleeding, but those risks must be weighed against the harm of doing nothing. He says physicians who don't give tPA often may be less up-to-date with recommendations for its proper use, and therefore fearful of administering it, especially to older, sicker patients.

Given his findings, Moradiya says he believes it would be valuable for physicians in hospitals without neurology residency programs to receive continuing education on the current research on tPA in an attempt to get the life-saving medication to appropriate patients more often.

People having strokes typically don't have an option of where to be taken for treatment, as many emergency medical services deliver them to the nearest hospital with a stroke unit (if there is one nearby).

Moradiya says it would be premature to suggest that patients try to be seen at hospitals with neurology residency programs if they are, say, 30 minutes further away. The trade-off in wasted time could be the difference in outcome in an instance where every minute counts. But if future research confirms his results, he says he could see a value in transporting stroke victims to a hospital where it is much more likely they will receive tPA.

###

The research was supported by grants from the National Institutes of Health's National Institute of Neurological Disorders and Stroke (U10NS077378, R25NS79211 and U10NS080377) and the National Heart, Lung, and Blood Institute (R01HL096944) to Steven R Levine of SUNY Downstate Medical Center, the supervising researcher of the study.

For more information: http://www.hopkinsmedicine.org/neurology_neurosurgery/specialty_areas/cerebrovascular/stroke/

Johns Hopkins Medicine (JHM), headquartered in Baltimore, Maryland, is a $6.7 billion integrated global health enterprise and one of the leading academic health care systems in the United States. JHM unites physicians and scientists of the Johns Hopkins University School of Medicine with the organizations, health professionals and facilities of The Johns Hopkins Hospital and Health System. JHM's vision, "Together, we will deliver the promise of medicine," is supported by its mission to improve the health of the community and the world by setting the standard of excellence in medical education, research and clinical care. Diverse and inclusive, JHM educates medical students, scientists, health care professionals and the public; conducts biomedical research; and provides patient-centered medicine to prevent, diagnose and treat human illness. JHM operates six academic and community hospitals, four suburban health care and surgery centers, and more than 35 Johns Hopkins Community Physicians sites. The Johns Hopkins Hospital, opened in 1889, was ranked number one in the nation for 21 years in a row by U.S. News & World Report. For more information about Johns Hopkins Medicine, its research, education and clinical programs, and for the latest health, science and research news, visit http://www.hopkinsmedicine.org.

Media Contacts: Stephanie Desmon
410-955-8665; sdesmon1@jhmi.edu
Helen Jones
410-502-9422; hjones49@jhmi.edu

END



ELSE PRESS RELEASES FROM THIS DATE:

Stanford researchers surprised to find how neural circuits identify information needed for decisions

2013-11-07
Stanford researchers surprised to find how neural circuits identify information needed for decisions Multitasking neurons filter and decide, confounding the conventional wisdom While eating lunch you notice an insect buzzing around your plate. Its color and ...

Researchers and clinicians unite to answer what will it take to achieve an AIDS-free world?

2013-11-07
Researchers and clinicians unite to answer what will it take to achieve an AIDS-free world? November 5, 2013, San Francisco, CA—Since the onset of the AIDS pandemic more than three decades ago, researchers from the lab and physicians in the clinic have been working toward one ...

Hormone levels in women using contraception affect nerve activity involved in vessel constriction

2013-11-07
Hormone levels in women using contraception affect nerve activity involved in vessel constriction Bethesda, Md. (Nov. 6, 2013)—After menopause, women's levels of estrogen and progesterone fall. Their formerly lower risk for heart disease equals, even surpasses, men's risk. ...

'Please feed me': The power of putting a human face on social causes

2013-11-07
'Please feed me': The power of putting a human face on social causes Companies often put a personal face on products in an attempt to reach a deeper connection with consumers. New research suggests the same idea can be applied to social ...

CWRU study finds mending ruptures in client-therapist relationship has positive benefits

2013-11-07
CWRU study finds mending ruptures in client-therapist relationship has positive benefits In order for prolonged exposure therapy, an evidence-based psychotherapy for post traumatic stress disorder (PTSD), to reach its full potential, any misperceptions ...

Mothers' relationships can influence adolescent children's relationships, MU study finds

2013-11-07
Mothers' relationships can influence adolescent children's relationships, MU study finds COLUMBIA, Mo. – Until now, little research has been conducted on the association between parents' friendships and the emotional well-being of their adolescent ...

UC's SmartLight more than a bright idea, it's a revolution in interior lighting ready to shine

2013-11-07
UC's SmartLight more than a bright idea, it's a revolution in interior lighting ready to shine The innovative solar technology 'would change the equation for energy,' according to UC researchers A pair of University of Cincinnati researchers has seen the light ...

Georgia Tech warns of threats to cloud data storage, mobile devices in latest 'emerging cyber threat'

2013-11-07
Georgia Tech warns of threats to cloud data storage, mobile devices in latest 'emerging cyber threat' As more businesses find their way into the cloud, few engage in security measures beyond those provided by the associated cloud storage firm, a new report ...

From 1 collapsing star, 2 black holes form and fuse

2013-11-07
From 1 collapsing star, 2 black holes form and fuse Black holes—massive objects in space with gravitational forces so strong that not even light can escape them—come in a variety of sizes. On the smaller end of the scale are the stellar-mass black holes that ...

Addicts may be seeking relief from emotional lows more than euphoric highs

2013-11-07
Addicts may be seeking relief from emotional lows more than euphoric highs Rutgers study could lead to a better understanding of human addiction -- alcohol, tobacco and food -- as well as substance abuse Cocaine addicts may become trapped in drug binges – not because of the euphoric ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Hospitals with neurology residency programs more likely to administer life-saving clot-busting drugs
tPA found underused; getting it depends on where patients are treated